BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36046312)

  • 1. Successful Neuromuscular Blockade Reversal Using Sugammadex and Neostigmine Failed to Prevent Myasthenic Crisis After Emergency Surgery: A Case Report.
    Haddad D; Hanna AJ; Russo L
    Cureus; 2022 Jul; 14(7):e27366. PubMed ID: 36046312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
    Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
    Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rocuronium Reversal in the Emergency Department: Retrospective Evaluation of Hemodynamic Instability Following Administration of Sugammadex Versus Neostigmine With Glycopyrrolate.
    Hile GB; Healy KJ; Almassalkhi LR
    J Pharm Pract; 2023 Apr; 36(2):336-341. PubMed ID: 34601981
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on Postoperative Gastrointestinal Motility After Neuromuscular Blockade Reversal With Sugammadex Versus Neostigmine/Glycopyrrolate in Colorectal Surgery Patients.
    Hunt ME; Yates JR; Vega H; Heidel RE; Buehler JM
    Ann Pharmacother; 2020 Dec; 54(12):1165-1174. PubMed ID: 32468846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex reversal of muscle relaxant blockade provided less Post-Anesthesia Care Unit adverse effects than neostigmine/glycopyrrolate.
    Chang HC; Liu SY; Lee MJ; Lee SO; Wong CS
    J Formos Med Assoc; 2022 Dec; 121(12):2639-2643. PubMed ID: 35577643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.
    Woo T; Kim KS; Shim YH; Kim MK; Yoon SM; Lim YJ; Yang HS; Phiri P; Chon JY
    Korean J Anesthesiol; 2013 Dec; 65(6):501-7. PubMed ID: 24427455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
    Paech MJ; Kaye R; Baber C; Nathan EA
    Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Sugammadex on Postoperative Myasthenic Crisis in Myasthenia Gravis Patients: Propensity Score Analysis of a Japanese Nationwide Database.
    Mouri H; Jo T; Matsui H; Fushimi K; Yasunaga H
    Anesth Analg; 2020 Feb; 130(2):367-373. PubMed ID: 31124838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery.
    Traeger L; Hall TD; Bedrikovetski S; Kroon HM; Dudi-Venkata NN; Moore JW; Sammour T
    Tech Coloproctol; 2023 Mar; 27(3):217-226. PubMed ID: 36064986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature.
    Fernandes HDS; Ximenes JLS; Nunes DI; Ashmawi HA; Vieira JE
    BMC Anesthesiol; 2019 Aug; 19(1):160. PubMed ID: 31421671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study.
    Kim NY; Koh JC; Lee KY; Kim SS; Hong JH; Nam HJ; Bai SJ
    J Clin Anesth; 2019 Nov; 57():97-102. PubMed ID: 30939422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.
    Carron M; Baratto F; Zarantonello F; Ori C
    Clinicoecon Outcomes Res; 2016; 8():43-52. PubMed ID: 26937203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center.
    Fiorda Diaz J; Echeverria-Villalobos M; Esparza Gutierrez A; Dada O; Stoicea N; Ackermann W; Abdel-Rasoul M; Heard J; Uribe A; Bergese SD
    Front Med (Lausanne); 2022; 9():1072711. PubMed ID: 36569123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain.
    Martinez-Ubieto J; Aragón-Benedí C; de Pedro J; Cea-Calvo L; Morell A; Jiang Y; Cedillo S; Ramírez-Boix P; Pascual-Bellosta AM
    BMC Anesthesiol; 2021 Feb; 21(1):55. PubMed ID: 33593283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation.
    Paton F; Paulden M; Chambers D; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
    Br J Anaesth; 2010 Nov; 105(5):558-67. PubMed ID: 20935005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.